Developing tools for early diagnosis and treatment of Alzheimer's

Tuesday, 31 January, 2017
image of elderly hands holding blurred photographs
PANA has set out to develop an innovative method to diagnose Alzheimer's in its early stages, up to five years before the occurrence of clinical symptoms. This could increase the duration and quality of patients' lives considerably.

Alzheimer’s disease is the leading cause of dementia and loss of autonomy among elderly people today, posing a huge challenge for families, medical professionals and society in general.

There is currently no effective method for early diagnosis of Alzheimer’s, which effectively limits the use of early therapeutic strategies to delay onset of the disease’s most adverse symptoms.

Read more

Project: 
PROMOTING ACTIVE AGEING: FUNCTIONAL NANOSTRUCTURES FOR ALZHEIMER’S DISEASE AT ULTRA-EARLY STAGES.
Project Acronym: 
PANA
Article
#H2020